Different Types of FDA 510k Submissions: Which is Right for Your Medical Device?

 When it comes to obtaining FDA 510k certification for medical devices, there are different types of submissions that can be made. Each type of submission has its own requirements and timelines.

It is important for medical device manufacturers to understand the different types of submissions and choose the one that is most appropriate for their device. In this blog, we will explore the different types of FDA 510k submissions and how to determine which one is right for your medical device.

1. Traditional 510k Submission: This is the most common type of 510k submission. It requires the manufacturer to demonstrate that their device is substantially equivalent to a predicate device that is already on the market. The submission includes a detailed comparison of the new device to the predicate device, as well as information on device performance, safety, and labeling. The review process typically takes 90 days.
2. Abbreviated 510k Submission: This type of submission is appropriate for devices that have a well-established predicate device on the market. It requires less information than a traditional 510k submission and the review process typically takes 60 days.
3. Special 510k Submission: This type of submission is used when modifications are made to a device that has already been cleared through a traditional or abbreviated 510k submission. It allows the manufacturer to demonstrate that the modifications do not significantly affect the safety or effectiveness of the device. The review process typically takes 30 days.
4. The Pre-Submission Program: The Pre-Submission Program, also known as a pre-sub, is not technically a 510k submission. Instead, it is an opportunity for manufacturers to discuss their device with the FDA before submitting a formal 510k application. The goal is to obtain feedback from the FDA on the device and the proposed testing methods. This can help manufacturers avoid potential pitfalls and streamline the 510k submission process.

So, which type of submission is right for your medical device? The answer depends on several factors, including the complexity of the device, the availability of predicate devices, and the modifications that have been made to the device. It is important for medical device manufacturers to work closely with their regulatory consultants to determine the appropriate submission type and to prepare a complete and accurate application.

In conclusion, there are different types of FDA 510k submissions available to medical device manufacturers. European Authorized Representative Each submission type has its own requirements and review process.

Medical device manufacturers should work with their regulatory consultants to determine which submission type is appropriate for their device, and to ensure that their application is complete and accurate. A successful 510k submission can result in FDA clearance and allow the device to be marketed in the United States.

 

Here's a Guide to FDA Registration

 A blog to help companies get FDA approval.

The United States Food and Drug Administration (FDA) is a government agency that regulates the safety of food and drugs in the country. All new medical devices and drugs must be approved by the FDA before they can be sold in the U.S.

This guide will walk you through the process of FDA registration to sell your product in the U.S. EU Declaration of Conformity Template The process can be a little confusing, which is why we made this resource to help you get your product on shelves quickly!

What is FDA Registration?

The Food and Drug Administration (FDA) registration is a requirement for any company that wants to sell its products in the United States. It's a way for the FDA to track the safety of products and their ingredients. It doesn't have any bearing on a company's manufacturing practices or quality control measures.

Which Foods Require FDA Registration?

The Food and Drug Administration (FDA) requires that food facilities have an FDA registration number before they can legally operate. This includes any place that manufactures, processes, packs or holds food for consumption in the United States.

The FDA uses this system to help ensure the safety of the food supply. Biocompatibility testing The agency can use a registration number to track specific products and companies, making sure they are following all regulations.

• Which Foods Require FDA Registration?
• Foods that require FDA registration include:
• Bakery products (breads, cakes, cookies, etc.)
• Dairy products (milk, cheese)
• Meat products (beef patties)
• Processed and canned foods (canned vegetables)
• Packaged foods (cereals, nuts)
• Seafood products

What is an FDA Facility Registration Number?

What is an FDA Facility Registration Number?

Your FDA facility registration number is a unique identifier given to each registered facility by the FDA. This number appears on any label or documentation related to your product, including labels on finished goods and shipping containers. It also appears on any documentation you send to customers or suppliers regarding your food products.

Why Do I Need a Facility Registration Number?

The main reason for registering your business with the FDA is so that you can legally sell your products within the United States. Without this registration number, it would be illegal for anyone who purchases from you — whether it's another manufacturer or an end consumer — to sell those products within the U.S., even if they're meant for export outside of our borders. This would also mean that consumers wouldn't be able to purchase them directly from you either!

What are the Benefits of FDA Compliance?

• Protecting Your Company's Reputation: If you're not registered with the FDA and your product causes a serious injury, it may be difficult to regain your customers' trust in future products unless you can show that you've taken steps to ensure that your manufacturing processes are safe and reliable.
• Avoiding Criminal Charges: The FDA's Center for Tobacco Products has prosecuted several cases against e-cigarette retailers who failed to register as manufacturers or importers. These cases have resulted in substantial fines and jail time for some defendants.
• Ensuring Your Products Are Safe: By registering with the FDA before selling any type of product, you'll be able to demonstrate that your manufacturing process meets federal standards for safety

If you have any questions about US FDA Registration or our company, we are available to help. Our office is open 8am-5pm, Monday-Friday. Visit our website www.i3cglobal.com

 

Best European Authorized Representative Services by i3cglobal company

 When a company based outside of the European Union (EU) wants to sell its medical device products in the EU, it is required to appoint a European Authorized Representative (EC REP). Here are some key points to keep in mind regarding European Authorized Representative Services:

What is a European Authorized Representative?

A European Authorized Representative (EC REP) is a legal entity that is appointed by a non-EUmanufacturer to act as its representative in the EU. FDA 510k Certification The EC REP is responsible for ensuring that the manufacturer's medical devices comply with EU regulations.

What are the responsibilities of a European Authorized Representative?

The responsibilities of a European Authorized Representative include ensuring that the manufacturer's medical devices are properly labeled, registered, and marketed in the EU according to the regulations. The EC REP also serves as a liaison between the EU authorities and the manufacturer.

What are the benefits of using a European Authorized Representative service?

Using a European Authorized Representative service can help manufacturers save time and money by providing a local presence in the EU.European Authorized Representative The EC REP can also help manufacturers navigate EU regulations and ensure compliance, reducing the risk of product recalls or delays in market entry.

How do I choose a European Authorized Representative?

When choosing a European Authorized Representative, it is important to consider their experience, reputation, and knowledge of EU regulations. The EC REP should have a thorough understanding of the medical device market and be able to provide comprehensive support to the manufacturer.

What are the risks of not appointing a European Authorized Representative?

Not appointing a European Authorized Representative can result in legal and financial consequences, including fines, product recalls, and delays in market entry. Additionally, without a local presence in the EU, it can be difficult to navigate the complex regulatory landscape and ensure compliance with EU regulations.

In summary, European Authorized Representative services are an essential component of selling medical devices in the EU. By understanding the responsibilities and benefits of using an EC REP, manufacturers can ensure compliance with EU regulations and successfully enter the market.

How to choose a European Authorized Representative?

 A blog about what a European Authorized Representative is and how you can choose one.

In this blog we will look at the representation system in the European Union and explain how it works. We'll explain what a European Authorized Representative is, tell you how its role is defined, and what you can expect from them.

A European Authorized Representative is a legal requirement for non-EU medical device manufacturers.

A European Authorized Representative (EAR) is a legal requirement for non-EU medical device manufacturers. This role has to be filled by a person, called the responsible representative, who will act on behalf of the manufacturer and with their power.

The EAR is responsible for ensuring that all documentation submitted to the competent authority satisfies all regulatory requirements, including technical documentation and registration forms. The EAR also has to ensure that any changes made to products are reported to the competent authority as soon as possible.

As an EAR, you must be able to demonstrate that you have sufficient knowledge of the European legislation that applies to your products. You will also need to know how these regulations apply in practice, so it is important to have a good understanding of how they work in practice too.

The European Authorized representative must be established in the EU.

The European Authorized representative is a person or a company that is established in the EU and has the legal authority to represent a foreign company.

The European representative must be established in the EU. In other words, they cannot be located in another country outside of Europe.

In addition to being established in the EU, the representative must be subject to the laws of that country as well as those of their own country.

The most common types of European authorized representatives include:

- An individual who acts as an authorized representative on behalf of a foreign company (an individual). This includes employees of foreign companies who are appointed as European Representatives.

- An agency established by law or by government regulation which represents multiple foreign companies (an agency).

The European Authorized Representative must be accessible to regulatory authorities at all times and act on the manufacturer’s behalf.

The European Authorized Representative must be accessible to regulatory authorities at all times and act on the manufacturer’s behalf.

The European Authorized Representative is a legal entity that has been recognized by a Member State to represent a company in relation to EU-wide approval procedures. The European Authorized Representative must be accessible to regulatory authorities at all times and act on the manufacturer’s behalf. The European Authorized Representative can be any type of entity: an individual, a company or an association. It is important to check if there are any restrictions on who can become a European Authorized Representative for your product.

The European Authorized Representative will receive requests from the CE marking authorities for information about your product and will respond accordingly. This means that you should provide them with all relevant information about your product, including copies of certificates and documents related to it. You should also inform them about any changes in this information so that they can update their records accordingly.

The European Authorized Representative is required to forward product recalls and vigilance reports to the manufacturer and supervise the implementation of corrective actions.

The European Authorized Representative (EAR) is the representative of a foreign manufacturer or importer in the EU, who is required to forward product recalls and vigilance reports to the manufacturer and supervise the implementation of corrective actions.

The EAR is also responsible for ensuring that all necessary information about a product or batch is forwarded to relevant authorities e.g. in case of a suspected or detected safety risk or quality issue. US FDA Certificate The EAR is also responsible for providing documentation on the use and maintenance of the product e.g. manuals, instructions for use, technical documentation etc., as well as any other documentation related to safety, health and environmental protection aspects of the product at hand.

A key function of an EAR is therefore to provide technical assistance during market surveillance activities by competent authorities.

The requirement to appoint an EAR was introduced through Regulation 1025/2009 (recast), which entered into force on 1 July 2011 and extended the scope of application of European legislation on consumer protection applicable within the EU market from consumer products only to all products placed on the market irrespective of whether they were produced in the EU or imported from outside Europe.

Nowadays it seems that regulatory burden is increasing, and as a result it is becoming increasingly important to register your manufacturing facilities and appoint an Authorized Representative in the European Union. Doing this correctly can help you avoid being subject to penalties due to non-compliance

Drug Master File

 Master records are authorized documents that contain the information to perform and control process operations and activities related to the manufacture of a product.

This article summarizes the requirements requested by the Food and Drug Administration (FDA) in its draft published in October for the master drug records or documents of pharmacological substances, packaging material, etc. The second section discusses the regulatory requirements for master documents submitted in sanitary registration applications in USA.

Guidance proposal for the industry

The FDA 510k Certification published in October the draft of the guide for the industry on the Master Drug File the guide provides the way to prepare the documentation on the facilities, processes or materials used in the manufacture, the manufacturing process, packaging and storage of medicines for human use.

The information described in the guide is not mandatory by any legal provision and the sending of the same is left to the consideration of the holders of the DMF. They can be used to support New Drug Applications (NDAs), Abbreviated New Drug Applications (ANDAs), and Investigational Drug Applications (INDs).

The guide proposes four types [1] of DMF's:

• Type II. Pharmacological substance, intermediate and its raw materials for its manufacture.
• Type III. Packaging materials.
• Type IV. Excipients, colorings, flavorings, essence or material used for its preparation.
• Type V. Accepted reference information.

Filing of the DMF is subject to the electronic filing requirements set forth in the Federal Food, Drug, and Cosmetic Act (FD&C Act) section 745A guidance and complying with the electronic common technical document (eCTD) format and Guidance ICH M4.

The DMF can be presented in original in the eCTD format, US FDA Registration for this the holders must have a pre-assigned number and a letter of presentation of technical administrative information based on the eCTD.

Clinical Evaluation for Medical Devices

 Clinical evaluation: The clinical evaluation report (CER) complies with the MEDDEV Guideline 2.7/1 rev. 4.

With the full implementation of the strict European Regulation (MDR 2017/745) in 2020, the issue of clinical evaluation has become a sore point for Medical Device manufacturers. Regardless of their risk class, all Medical Devices marketed in Europe are subject to the clinical evaluation process, in accordance with point 6 bis of Annex I of Directive 2007/47/CE. The Clinical Evaluation report (CER) alone is no longer enough.

While once considered just an element of the technical file, today the REC according to the latest version of the MEDDEV Guideline 2.7/1 (rev.4) is, in fact, the final phase of a carefully planned clinical evaluation process. Even if products are already CE marked, manufacturers must keep up with ever-higher standards because Notified Body (NO) control of clinical assessment and ERC will only intensify as 2020 approaches.

The MEDDEV Guideline 2.7/1 rev.4 defines clinical evaluation as a procedure that involves the collection, estimation, analysis and evaluation of the clinical data available to support the compliance of the Medical Device with the Essential Requirements (ER). In other words, the clinical data serve as evidence that, if used in accordance with the manufacturer's IFUs, the Medical Device is safe, has the claimed performance and any unwanted side effects, compared to the clinical benefit of the device, is considered acceptable.

So how can manufacturers ensure that their clinical evaluation process and RECs meet the latest regulatory expectations expressed in MEDDEV 2.7/1 rev.4?

Here are some helpful ideas to consider:

Define clear objectives in the CER. Identify relevant ERs supported by clinical trials (based on device specifications) and define the scope of clinical evaluation, i.e., specific and measurable goals related to safety, performance, and risk/benefit endpoints;

Define if a clinical investigation is required . Make sure that the available clinical trials are sufficient and adequate to answer all relevant ERs. As a general rule, high-risk and Class III devices should always undergo clinical investigation, as well as those based on innovative or unproven technologies, and those claiming a new clinical use;

Prepare a “bulletproof” Equivalence Proof . Based on the comparison between the device in question and several CE-marked equivalent devices available on the market, the demonstration of equivalence is established in terms of clinical, technological and biological parameters (defined by the manufacturer) and must be very detailed. at CER.

To provide a proper proof of equivalence, carefully documented information is required for each equivalent device. In addition, the differences between the device in question and the equivalent devices must be identified, disseminated, evaluated and justified;

Monitor post-marketing activities (PMS and PMCF). Plan an appropriate PMCF, document all findings in the CER, and ensure you have processes for PMS and PMCF in place. These must be "living" documents because the security and performance of a device must be confirmed throughout its life cycle;

Update the CER frequently . Define the CER update frequency and justify it. The CER is also a "living" document and therefore whenever new post-marketing surveillance data emerge that could influence the CER findings, they should be revised. Also, changes to the state of the art and current knowledge about equivalent devices should trigger a CER review. Devices used for comparison should always be kept relevant.

Under the strict requirements of the MDR that reflect the high expectations of the European Commission, NOs will question both the quality of clinical evidence (hence the criteria that include such data in clinical evaluation) and the basis for establishing equivalence with another device. . The stakes are high: they must ensure that only high-quality, safe and effective Medical Devices are placed on the European market.

Manufacturers preparing for new legislation have MEDDEV 2.7/1 rev.4 at their disposal to use as a roadmap to guide their transition. CERs based solely on demonstrating clinical equivalence will no longer suffice, especially for high-risk devices, which likely require clinical investigations. Only by aligning and integrating the CER with risk management, surveillance and post-market supervision activities will compliance with the requirements of the European MDR be achieved.

Responsibilities of the EU Authorized Representative

A European Authorized EU Representative is defined as a natural or legal person within the European Union who has accepted a written mandate from a manufacturer, located outside the EU, to act on its behalf in relation to specific tasks under MDR or IVDR. Specifically, Authorized Representatives play a critical role in ensuring device compliance and serving as a point of contact for European authorities and notified bodies.

MDR and IVDR describe the tasks that the manufacturer can delegate to the Authorized Representative and the conditions under which this can be carried out. This relationship must be covered by a precise mandate agreed between the EC REP and the manufacturer. The Authorized Representative will carry out the tasks specified in the mandate. A copy of the mandate will be provided by the Authorized Representative to the competent authority, upon request.

The Authorized Representative is responsible for defective medical devices along with the manufacturer, as well as any default by the manufacturer.

Mandatory tasks of the Authorized Representative according to MDR and IVDR

MDR and IVDR clearly describe the core role of the Authorized Representative and their obligations, which should be mentioned in the mandate:

• Verify that the EU declaration of conformity and the technical documentation of the product have been drawn up and, where appropriate, that the manufacturer has followed the relevant conformity assessment procedure.
• Keep a copy of the technical documentation, the EU declaration of conformity and, where appropriate, a copy of the corresponding certificate, including its modifications and supplements, available to the competent authorities.
• Comply with FDA Registration obligations.
• In response to the request of a competent authority, provide it with all the information and documentation necessary to demonstrate the conformity of the product.
• Transmit to the manufacturer any request for samples or access to a product by a competent authority of the Member State in which the authorized representative has its registered office, and verify that said authority receives them or that access is granted.
• Cooperate with the competent authorities in any preventive or corrective action taken to eliminate or, if this is not possible, mitigate the risks posed by the products.
• Immediately notify the manufacturer of claims and reports from health professionals, patients or users about alleged incidents related to a product for which it has been designated.